Post-earnings recap
Reported
Wed, Jul 30, 2014
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Haemonetics Corp reported an EPS of $0.33, slightly missing expectations. The stock reacted negatively, dropping 0.33%. The lack of revenue data and guidance may have contributed to investor caution.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.33 | N/A | -5.98% |
Management expressed concerns about market conditions impacting performance. They highlighted efforts to improve operational efficiency.
Management noted challenges in the current market environment.
They emphasized a focus on operational efficiency moving forward.